Your browser is no longer supported. Please, upgrade your browser.
Settings
TEVA Teva Pharmaceutical Industries Limited daily Stock Chart
TEVA [NYSE]
Teva Pharmaceutical Industries Limited
Index- P/E- EPS (ttm)-16.84 Insider Own2.70% Shs Outstand1.01B Perf Week3.48%
Market Cap21.39B Forward P/E7.48 EPS next Y2.82 Insider Trans2.74% Shs Float976.86M Perf Month18.35%
Income-17111.00M PEG- EPS next Q0.63 Inst Own67.40% Short Float5.51% Perf Quarter5.56%
Sales21.82B P/S0.98 EPS this Y-34.40% Inst Trans12.87% Short Ratio4.77 Perf Half Y64.89%
Book/sh14.68 P/B1.44 EPS next Y6.73% ROA-20.60% Target Price19.44 Perf Year-29.42%
Cash/sh1.40 P/C15.08 EPS next 5Y-7.82% ROE-82.20% 52W Range10.85 - 33.82 Perf YTD11.29%
Dividend0.85 P/FCF6.83 EPS past 5Y-57.50% ROI-36.00% 52W High-37.37% Beta0.73
Dividend %4.03% Quick Ratio0.60 Sales past 5Y2.00% Gross Margin47.50% 52W Low95.21% ATR0.66
Employees51800 Current Ratio1.00 Sales Q/Q-10.40% Oper. Margin-77.70% RSI (14)76.41 Volatility2.53% 3.75%
OptionableNo Debt/Eq2.06 EPS Q/Q81.40% Profit Margin-73.60% Rel Volume1.01 Prev Close21.09
ShortableYes LT Debt/Eq1.97 EarningsMay 03 BMO Payout- Avg Volume11.27M Price21.18
Recom3.10 SMA2011.00% SMA5016.12% SMA20021.45% Volume704,934 Change0.43%
Mar-20-18Resumed Jefferies Hold $19
Feb-12-18Upgrade Credit Suisse Neutral → Outperform
Feb-09-18Upgrade RBC Capital Mkts Underperform → Sector Perform
Feb-09-18Downgrade Piper Jaffray Neutral → Underweight
Feb-09-18Downgrade Gabelli & Co Buy → Hold
Feb-02-18Downgrade BTIG Research Neutral → Sell $17
Jan-26-18Reiterated Leerink Partners Underperform $15 → $17
Jan-25-18Reiterated Susquehanna Positive $22 → $24
Jan-18-18Downgrade BTIG Research Buy → Neutral
Jan-09-18Upgrade Mizuho Neutral → Buy $23
Jan-05-18Downgrade Wells Fargo Market Perform → Underperform
Jan-04-18Upgrade Citigroup Neutral → Buy
Jan-03-18Initiated Leerink Partners Underperform $15
Dec-15-17Upgrade Morgan Stanley Underweight → Equal-Weight
Dec-15-17Upgrade Goldman Neutral → Buy
Dec-15-17Upgrade Credit Suisse Underperform → Neutral
Dec-12-17Initiated Guggenheim Neutral $16
Nov-29-17Reiterated Mizuho Neutral $12 → $16
Nov-17-17Reiterated Mizuho Neutral $15 → $12
Nov-13-17Downgrade JP Morgan Neutral → Underweight
May-19-18 04:10PM  Cantor Fitzgerald: 18 Drug Companies With Catalysts Worth Watching Benzinga
May-18-18 05:10PM  CORRECTING and REPLACING Teva Announces Publication of Phase III Trial Data of Fremanezumab for the Preventive Treatment of Episodic Migraine in the Journal of the American Medical Association Business Wire
02:35PM  Pharma Stock Roundup: Zoetis to Buy Abaxis, NVS Gets FDA Nod for Migraine Drug Zacks
09:56AM  Amgen's Migraine Drug Aimovig Gets FDA Approval, Shares Up Zacks
07:25AM  Free Stock Performance Review on Teva Pharma and Three Other Healthcare Sector ACCESSWIRE
06:08AM  Buffett Gets Even Greedier With Teva Pharmaceuticals. Time to Buy? Motley Fool
06:00AM  13F: Buffett Increased Apple, Monsanto & Teva Investopedia
May-17-18 10:23AM  Company News For May 17, 2018 Zacks
09:46AM  The Top Stocks Warren Buffett Is Buying Now Motley Fool
May-16-18 03:19PM  Warren Buffett Pushing More Cash To Equities; 'Big 5' Stocks Still At The Top Benzinga
01:32PM  Berkshire doubles Teva stake, adds to Apple, ends a newspaper bet Reuters
12:08PM  Teva Pharmaceutical Industries Ltd, Once a Falling Machete, Is Spiking Chase It InvestorPlace
11:50AM  Berkshire doubles Teva stake, adds to Apple, ends a newspaper bet Reuters
11:47AM  Corrected: Berkshire doubles Teva stake, adds to Apple, ends a newspaper bet Reuters
09:56AM  Eli Lilly's Cluster Headache Candidate Succeeds in Phase III Zacks
09:38AM  Stocks Inch Up, Dow Jones Lags; Boot Barn Spikes Out Of Buy Range Investor's Business Daily
09:34AM  Teva Shares Jump After Warren Buffett Doubles Stake in Drugmaker TheStreet.com
09:07AM  Teva Stock Up 5% as Buffett's Berkshire Raises Stake in Q1 Zacks
07:25AM  Buffett Buys More Apple and Teva Shares, Dumps IBM Investopedia
06:00AM  Here's What Warren Buffett Is Buying and Selling Motley Fool
May-15-18 05:52PM  Buffett's company doubles investment in drugmaker Teva Associated Press
05:50PM  After-hours buzz: TEVA, MON, MU & more CNBC
05:43PM  Berkshire doubles Teva stake, adds to Apple, ends a newspaper bet Reuters
05:35PM  Teva shares up 5% on Berkshire's increased stake MarketWatch
04:46PM  Buffett's Berkshire adds to stakes in Teva and Monsanto in the first quarter CNBC
04:38PM  Berkshire Hathaway doubles Teva bet, confirms Apple purchases Reuters
04:34PM  Berkshire Hathaway doubles Teva bet, confirms Apple purchases Reuters
02:28PM  Nektar Therapeutics Stock Is Risky But Offers Big Reward InvestorPlace
11:05AM  Teva Announces Publication of Phase III Trial Data of Fremanezumab for the Preventive Treatment of Episodic Migraine in the Journal of the American Medical Association Business Wire
08:00AM  Todays Research Reports on Stocks to Watch: Precipio and Teva Pharmaceutical ACCESSWIRE
May-14-18 04:55PM  Teva Pharma Spiked To Perrigo's Detriment On Asthma Inhaler Delay Investor's Business Daily +5.54%
11:00AM  EGLT: Partnerships and Formulary Adds Impressive; Waiting for Revenue Catch Up Zacks Small Cap Research
May-13-18 09:52AM  Insider Buys Of The Week: ADS, Tesla, Teva And More Benzinga
May-11-18 05:07PM  Perrigo Drops After Saying FDA to Reject Inhaler, Delaying Start Bloomberg
05:02PM  [$$] FDA Rejects Perrigo's ProAir Generic, Drug Maker Says The Wall Street Journal
May-08-18 02:11PM  Warren Buffett's 10 Big Stock Losers Investopedia
May-07-18 04:32PM  Why Teva Pharmaceutical Industries, Gramercy Property Trust, and Medtronic Jumped Today Motley Fool
08:17AM  Teva (TEVA) Stock Dips Despite Q1 Earnings & Sales Beat Zacks
May-05-18 11:03AM  Will Teva Stock Break Down From Key Support? Investopedia
May-04-18 08:30AM  Today's Research Reports on Trending Tickers: Sarepta Therapeutics and Teva Pharmaceutical Industries ACCESSWIRE
May-03-18 08:35PM  Teva Shows Progress on Restructuring But Investors Want More TheStreet.com
04:42PM  Teva Pulls Off Quarterly Beat Despite Generic Copaxone Worries Investor's Business Daily
11:48AM  Teva beats first-quarter expectations but still has the same old problems MarketWatch
11:39AM  Teva reports jump in first-quarter earnings, raises guidance Associated Press
11:39AM  Teva reports jump in first-quarter earnings, raises guidance Associated Press
11:24AM  Teva raises 2018 outlook, expects migraine drug approval by year-end Reuters
11:19AM  Teva raises 2018 outlook, expects migraine drug approval by year-end Reuters
10:59AM  Teva Earnings: Shares Climb, CEO Highlights Growing Stability Barrons.com
10:57AM  MARKETS: Blue Apron stock climbs wall of worry as loss not as great as expected Yahoo Finance Video
09:31AM  Benzinga Pro's 5 Stocks To Watch Today Benzinga
08:41AM  Teva (TEVA) Up on Q1 Earnings & Sales Beat, Rise in Guidance Zacks
08:25AM  Teva Shares Spike After Q1 Earnings Beat, Full Year Forecast Boost TheStreet.com
07:46AM  Teva shares surge 6.5% on Q1 beats, higher 2018 guidance MarketWatch
07:07AM  Teva Pharm Q1 profit down less than forecast, raises 2018 outlook Reuters
07:00AM  Teva Reports First Quarter 2018 Financial Results Business Wire
May-02-18 02:27PM  Earnings Preview: What To Expect From Teva On Thursday Forbes
08:00AM  Teva to Present AUSTEDO® (deutetrabenazine) Tablets Data at the American Psychiatric Association 2018 Annual Meeting Business Wire
05:10AM  Teva Pharma opts to maintain Israeli logistics centre Reuters
May-01-18 07:15PM  Wall Street Has Given Up on These 3 Stocks, and That's a Huge Mistake Motley Fool
02:49PM  Allergan CEO Says Splitting Company Among Options Under Review Bloomberg Video
10:18AM  Teva (TEVA) to Report Q1 Earnings: What's in the Cards? Zacks
Apr-27-18 03:50PM  Teva Presents New Long-Term Data Demonstrating Efficacy and Safety of COPAXONE® (glatiramer acetate injection) 40 mg/mL Business Wire
Apr-26-18 04:26AM  Teva to reduce size of board after June shareholders meeting Reuters
04:15AM  Teva to reduce size of board after June shareholders meeting Reuters
Apr-25-18 06:25PM  Aceto's Search for Deal May Be Slowed by DOJ Subpoena TheStreet.com
Apr-24-18 01:27PM  Express Scripts targets Amgen, Lilly migraine drugs in pricing shift Reuters
10:44AM  NEWS BITES: Police look for motive in deadly Toronto van attack, President George H.W. Bush hospitalized, Prince's family suing hospital that treated him Yahoo Finance Video
07:36AM  Express Scripts targets new migraine drugs to change U.S. pricing dynamic Reuters
07:00AM  FOCUS-Express Scripts targets new migraine drugs to change U.S. pricing dynamic Reuters
Apr-23-18 02:48PM  Mylan NV Still Undervalued Despite Unveiling of New Products InvestorPlace
08:30AM  Teva to Report First Quarter 2018 Financial Results on May 3, 2018 Business Wire
Apr-19-18 04:30PM  MARKETS: Today's winning stocks are more interesting than the losers, like Procter & Gamble Yahoo Finance Video
12:36PM  Teva, Procter & Gamble to dissolve OTC partnership. American City Business Journals
07:37AM  P&G sales, earnings per share climb American City Business Journals
07:00AM  Teva and the Procter & Gamble Company Have Agreed to Terminate the PGT Healthcare Partnership Business Wire
Apr-17-18 08:00AM  Teva to Present New Data Across Multiple Therapeutic Areas at 70th Annual Meeting of the American Academy of Neurology Business Wire
Apr-16-18 11:29PM  Pfizer Inc. Stock Has a Great Storyline Thats Not Panning Out InvestorPlace
01:40PM  MARKETS: These are the top risks CEOs are citing this earnings season Yahoo Finance Video
Apr-15-18 08:14AM  Israeli unions warn Teva Pharm over plan to close Ashdod plant Reuters
07:37AM  Israeli unions warn Teva Pharm over plan to close Ashdod plant Reuters
Apr-13-18 06:31PM  3 Top Healthcare Stocks to Buy in April Motley Fool
01:02PM  8 Contrarian Stock Picks for a Rocky Market: CS Investopedia
Apr-11-18 05:00AM  Are Drug Prices Too Low? Bloomberg
Apr-10-18 02:05PM  MARKETS: Welcome to the low volume, low liquidity algo-driven market Yahoo Finance Video
08:20AM  Todays Research Reports on Stocks to Watch: Teva and Therapix ACCESSWIRE
Apr-09-18 03:31PM  AssistRx co-founder: Why company took on Teva employees, lease in OP American City Business Journals
02:22PM  Teva Chairman Says Tariffs Won't Have a Major Impact on Biotech Bloomberg Video
09:59AM  Teva Pharm to close plant in Israel after no buyer found Reuters
Apr-03-18 04:04PM  Teva sells OP business segment American City Business Journals
08:10AM  Todays Research Reports on Stocks to Watch: Alkermes and Teva ACCESSWIRE
Mar-29-18 06:06AM  Stark Wipes Out $235M Infringement Verdict Against Teva for Hypertension Drug ALM Media
Mar-28-18 05:21PM  Teva wins reversal of U.S. jury's $235 million GSK drug patent verdict Reuters
05:18PM  UPDATE 2-Teva wins reversal of U.S. jury's $235 mln GSK drug patent verdict Reuters
11:39AM  Teva Wins Ruling Tossing $235 Million Glaxo Drug Verdict Bloomberg
Mar-27-18 08:25AM  Analysis: Positioning to Benefit within PagSeguro Digital, Piedmont Office Realty Trust, Teva Pharmaceutical Industries, Obsidian Energy, HSBC Holdings plc, and ICICI Bank Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
Mar-26-18 05:24PM  Teva Analyst: Wall Street's Forecasts Look 'Overly Ambitious' TheStreet.com
02:49PM  Teva Announces the Launch of a Generic Version of Lialda® in the United States Business Wire
01:39PM  MARKETS: The S&P 500 just opened the strongest since right after Lehman failedwhich is telling Yahoo Finance Video
Mar-23-18 01:27PM  Teva Announces the Launch of a Generic Version of ALOXI® in the United States Business Wire
Mar-22-18 12:18PM  Mesoblast's Delayed Launches, Teva Split Turn Credit Suisse Bearish Benzinga
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines and a portfolio of specialty medicines worldwide. It operates through two segments, Generic Medicines and Specialty Medicines. The Generic Medicines segment offers sterile products, hormones, narcotics, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, ointments, and creams. This segment also develops, manufactures, and sells active pharmaceutical ingredients. The Specialty Medicines segment provides specialty medicines for use in central nervous system and respiratory indications. Its products in the central nervous system area comprise Copaxone for the treatment of relapsing forms of MS; and AUSTEDO for the treatment of tardive dyskinesia and chorea associated with Huntington disease. This segment's products in the respiratory market include ProAir, ProAir Respiclick, QVAR, Duoresp Spiromax, Qnasl, Braltus, Cinqair/Cinqaero, and Aerivio Spiromax for the treatment of asthma and chronic obstructive pulmonary disease, as well as Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim products in the oncology market. The company has collaboration arrangements with Otsuka Pharmaceutical Co. Ltd. and Regeneron Pharmaceuticals, Inc. Teva Pharmaceutical Industries Limited was founded in 1901 and is headquartered in Petach Tikva, Israel.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MIGNONE ROBERTODirectorMay 10Buy19.32250,0004,829,7001,500,000May 11 04:15 PM
MIGNONE ROBERTODirectorMay 09Buy19.21500,0009,603,1501,250,000May 11 04:15 PM
Stark David MatthewExec. VP Chief Legal OfficerMar 19Sale18.382,35843,3402,974Mar 20 04:16 PM
O'Grady Brendan P.EVP, North America CommercialMar 19Sale17.881,17921,0781,388Mar 20 04:13 PM
Nazzi GianfrancoEVP, Growth Markets CommercialMar 19Sale17.894578,1775,746Mar 20 04:11 PM
McClellan Michael JamesEVP, Chief Financial OfficerMar 19Sale17.882875,13111,295Mar 20 04:10 PM
Griffin Deborah AChief Accounting OfficerMar 19Sale17.8894316,8590Mar 20 04:08 PM
Fridriksdottir HafrunExecutive VP, Global R&DMar 19Sale17.883486,2227,051Mar 20 04:07 PM
Dethlefs SvenEVP Global Marketing&PortfolioMar 19Sale17.8857110,2084,445Mar 20 04:06 PM
Daniell RichardExec. VP, European CommercialMar 19Sale17.891,29723,2060Mar 20 04:04 PM
Stark David MatthewExec. VP Chief Legal OfficerMar 12Sale19.202,44146,8672,974Mar 14 04:35 PM
O'Grady Brendan P.EVP, North America CommercialMar 12Sale19.4973814,3831,388Mar 14 04:34 PM
Nazzi GianfrancoEVP, Growth Markets CommercialMar 12Sale19.504618,9895,331Mar 14 04:31 PM
Griffin Deborah AChief Accounting OfficerMar 12Sale19.4995218,5540Mar 14 04:29 PM
Dethlefs SvenEVP Global Marketing&PortfolioMar 12Sale19.4957611,2263,837Mar 14 04:26 PM
Daniell RichardExec. VP, European CommercialMar 12Sale19.5071413,9220Mar 14 04:23 PM
O'Grady Brendan P.EVP, North America CommercialMar 05Sale19.3870513,6631,388Mar 06 04:20 PM
Griffin Deborah AChief Accounting OfficerMar 05Sale19.3877314,9810Mar 06 04:14 PM
Daniell RichardExec. VP, European CommercialMar 05Sale19.281,10821,3620Mar 06 04:08 PM
Sabag MarkEVP, Global Human ResourcesFeb 15Sale20.523,00061,56041,517Feb 20 08:31 AM
Sabag MarkEVP, Global Human ResourcesFeb 14Sale18.452,05037,82344,517Feb 20 08:31 AM